COVID-19 Impact on Global Clinical Trials

Interactive visualizer showing how COVID-19 affected global clinical trial activity, comparing COVID-19 and non-COVID-19 studies from 2015 to 2022.

COVID-19 Impact on Global Clinical Trials

Interactive visualizer showing how COVID-19 affected global clinical trial activity, comparing COVID-19 and non-COVID-19 studies from 2015 to 2022.

Observing Change in Clinical Research During the Pandemic

The COVID-19: Global Impact on Clinical Trials visualizer is an interactive learning tool that brings together global clinical trial data to support reflection on how the pandemic affected research activity. It enables users to view trends over time and compare COVID-19–related and non-COVID-19 trials at global and country levels.

The visualizer exists to help clinical, quality, and regulatory professionals examine how trial conduct, focus areas, and reported activity shifted during a period of significant disruption. By structuring the data visually, it supports interpretation of patterns rather than assumptions about performance or causality.

What You Can Do With the Visualizer

Ways to explore pandemic-related shifts in trials

Compare COVID-19 and Non-COVID-19 Activity

Observe differences in trial volume over time to understand how research attention shifted during the pandemic years at global and national levels.

Review Trial Characteristics

Examine how trial status, phase, intervention type, and primary disease distribution differed between COVID-19 and non-COVID-19 studies.

Track Trends Across Years

Follow changes from 2015 to 2022 to place pandemic effects in a longer-term context, including pre-pandemic and recovery periods.

Data Source and Comparative Logic

The visualizer is based on publicly available trial records from ClinicalTrials.gov, covering the period from 2015 to 2022. The visual structure focuses on side-by-side comparisons across multiple dimensions, allowing users to explore how reported trial characteristics evolved without implying judgments on quality or outcomes.

What can these comparisons tell you?
Use the visuals to identify patterns and ask informed questions about how global events influenced trial activity, design focus, and reporting trends.

Interactive Visualizers for Shared Learning

The eyesON series is a collection of interactive visual tools designed to support understanding of complex topics in clinical research and regulation. Each visualizer emphasizes clarity, transparency, and thoughtful exploration of real-world data.

Cyntegrity offers the eyesON series as an educational contribution to the clinical research community, drawing on internal experience in data analysis and regulatory-focused work to make industry data more accessible. Explore More Interactive Visualizers…

Explore Our Visualizer

See how other datasets can sharpen signal awareness and decision-making.

Stay Informed with Us

RBQM Protocol Design: Why Monitoring Starts Before First Patient

Risk-based quality management begins in protocol design. See how ICH E6(R3) shifts oversight from monitoring plans to decision logic. ...

20 February 2026
9:51 AM

Risk-Based Quality Management in Medical Devices: ISO 14155 vs ICH E6(R3)

Medical device investigations are now assessed like RBQM trials. Learn how ISO 14155 and ICH E6(R3) align and download the practical translation guide....

17 February 2026
8:54 AM

Media Inquiries

Need a quote, speaker, or more info about Cyntegrity? Reach out directly to our media contact for timely assistance.